reports
Solésence Announces Key Leadership Appointments to Drive Future Innova...
Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth Strategic transformation of Solésence continues with Kevin Cureton promoted to President and Chief Executive Officer; Laura Riffner named Chief Financial Officer; Jess Jankowski to serve as Board Advisor ROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced strategic changes to its executive leadership. Kevin Cureton, a driving force behind the company’s expa...
Sana Biotechnology to Present at September 2025 Investor Conferences
Sana Biotechnology to Present at September 2025 Investor Conferences SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update. Sana will present at Citi’s 2025 Biopharma Back-to-School Conference at 3:15 p.m. ET on Tuesday, September 2, 2025.Sana will present at the 2025 Wells Fargo Healthcare Conference at 8:00 a.m. ET on ...
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’...
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common stock at a price to the public of $3.35 per share, pursuant to the exercise in full of the underwriters’ option to purchase additional shares in connection with Sana’s previously announced underwritten public offering, which closed on...
Mercury Signs New Hardware Production Agreement with AV to Support U.S...
Mercury Signs New Hardware Production Agreement with AV to Support U.S. Space Force’s SCAR Program ANDOVER, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing to the edge, today announced a new production agreement with AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) to support the U.S. Space Force’s Satellite Communication Augmentation Resource (SCAR) program. AV was awarded the $1.4 billion SCAR contract in 2022 by the Space Rapid Capabilities Office (RCO), a direct reporting unit of the Space Force....
Sana Biotechnology Reports Second Quarter 2025 Financial Results and B...
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates Presented positive 6-month clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with stable C-peptide New England Journal of Medicine published positive 12-week clinical results of the type 1 diabetes study Recent FDA INTERACT meeting increases confidence in moving forward with GMP master cell bank for SC451 and in filing SC451 Investigational N...
Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results
Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results Record Q4 FY25 Bookings of $341.5 million; book-to-bill of 1.25Record backlog of $1.40 billion; up 6% year-over-yearQ4 FY25 Revenue of $273.1 million; GAAP net income of $16.4 million; and adjusted EBITDA of $51.3 millionQ4 FY25 Operating Cash Flow of $38.1 million with Free Cash Flow of $34.0 million, with record free cash flow of $119.0 million for FY25 ANDOVER, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), reported operating results for the fourth quarter and fiscal year 2025, ended Jun...
- Jonathan Moreland
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TFX TELEFLEX INCORPORATED
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SHBI SHORE BANCSHARES INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
OPK OPKO HEALTH INC.
NSP INSPERITY INC.
NPO ENPRO INDUSTRIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
LLY ELI LILLY AND COMPANY
KMPR KEMPER CORPORATION
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
EIG EMPLOYERS HOLDINGS INC.
CNOB CONNECTONE BANCORP INC.
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CHD CHURCH & DWIGHT CO. INC.
CDXS CODEXIS
ARW ARROW ELECTRONICS INC.
AMH AMERICAN HOMES 4 RENT CLASS A
CIVB CIVISTA BANCSHARES
OLN OLIN CORPORATION
ASUR ASURE SOFTWARE INC
BRO BROWN & BROWN INC.
CYRX CRYOPORT INC.
FTV FORTIVE CORP.
CLAR CLARUS CORPORATION
A2H9KJ NEO PERFORMANCE MATERIAL
OSPN ONESPAN
FXNC FIRST NATIONAL CORP. OF VIRGINIA
TROX TRONOX HOLDINGS PLC
MEC MAYVILLE ENGINEERING
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
XRX XEROX HOLDINGS CORPORATION
PINE ALPINE INCOME PROPERTY TRUST
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
LRMR LARIMAR THERAPEUTICS INC
THRY THRYV HOLDINGS
DLHC DALEIGH HOLDINGS CORP
INTA INTAPP INC
PTLO PORTILLOS INC
BRBR BELLRING BRANDS INC
AUB ATLANTIC UNION BANKSHARES CORP
AURX NUO THERAPEUTICS
OI INC.
SIRI OWENS ILLINOIS INC.
XELB SIRIUS XM HLDGS INC NEW
MUSA XCEL BRANDS INC.
LNW METALS USA HOLDINGS CORP.
LIGHT & WONDER INC.
Sana Biotechnology Announces Pricing of Public Offering
Sana Biotechnology Announces Pricing of Public Offering SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20,895,522 shares of its common stock at a price to the public of $3.35 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,492,537 shares of common stock at a price to the public of $3.3499 per pre-funded warrant, which represents the per share publ...
Sana Biotechnology Announces Proposed Public Offering of Common Stock ...
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Sana intends to grant the underwriters a 30-day option to purchase up to an additiona...
Shore Bancshares Inc: 1 director
A director at Shore Bancshares Inc bought 10,000 shares at 15.000USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
- Jonathan Moreland
SNV SYNOVUS FINANCIAL CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SHBI SHORE BANCSHARES INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CDXS CODEXIS
ARW ARROW ELECTRONICS INC.
PETS PETMED EXPRESS INC.
PLBC PLUMAS BANCORP
CYRX CRYOPORT INC.
FTV FORTIVE CORP.
CMTV COMMUNITY BANCORP INC. VT
LRMR LARIMAR THERAPEUTICS INC
AURX NUO THERAPEUTICS
SIRI INC.
SIRIUS XM HLDGS INC NEW
Sana Biotechnology Announces Publication in New England Journal of Med...
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic Islet Cells Without Immunosuppression and Overcome Both Allogeneic and Autoimmune Rejection ...
Solésence Reports Second Quarter 2025 Financial Results
Solésence Reports Second Quarter 2025 Financial Results Strong commercial execution drove revenue growth of 56% to $20.4 million ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025. Recent Highlights and Accomplishments Joined broad-market Russell 3000® and small-cap Russell 2000® IndexesAmended loan agreements to fuel growth initiatives “During our seasonally highest-pe...
Solésence To Report Second Quarter 2025 Financial Results and Host a C...
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2025 after the market close on Thursday, July 31, 2025, and host a conference call and webcast on the same date. Second Quarter 2025 Conference Call Details Date / Time: Thursday, July 31, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT Speakers: Jess Janko...
Mercury Systems to Report Fourth Quarter and Full Year Fiscal Year 202...
Mercury Systems to Report Fourth Quarter and Full Year Fiscal Year 2025 Financial Results on August 11, 2025 ANDOVER, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Mercury Systems Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing to the edge, will release its fourth quarter and full year fiscal year 2025 financial results after the market close on Monday, August 11, 2025. Management will host a conference call and simultaneous webcast at 5:00 p.m. ET on the same day to discuss Mercury's quarterly financial results, business highlights, and outlook. In add...
Mercury Expands Processing Hardware Production Agreements with Europea...
Mercury Expands Processing Hardware Production Agreements with European Defense Prime Contractor ANDOVER, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing to the edge, today announced it signed two agreements with a European defense prime contractor to expand and accelerate production of processing subsystems and components for radar and electronic warfare missions. In June, Mercury extended this decades-long customer relationship with a five-year agreement that will enable faster, higher-volum...
Mercury Receives Two New Common Processing Architecture Production Awa...
Mercury Receives Two New Common Processing Architecture Production Awards ANDOVER, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing to the edge, today announced it received two new production awards in June totaling $36.9 million for ground-based radar programs that leverage its Common Processing Architecture and cybersecurity software from recently acquired Star Lab. “We continue to see strong demand for secure, high-performance processing solutions at the edge,” said Tom Smelker, Mercury’s Se...
Mercury Selected to Improve U.S. Defense Supply Chain Resilience for P...
Mercury Selected to Improve U.S. Defense Supply Chain Resilience for Priority Domestic Microelectronics Technology ANDOVER, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing to the edge, today announced it has been selected by the U.S. Department of Defense (DoD) for funding through its Industrial Base Analysis and Sustainment (IBAS) Program to develop a next-generation RF signal conditioning multi-chip package (MCP). The IBAS Program aims to improve the readiness and competitiveness of the defen...
Solésence to Join Russell 3000® and Russell 2000® Indexes
Solésence to Join Russell 3000® and Russell 2000® Indexes ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it will be added as a member of the broad-market Russell 3000® and small-cap Russell 2000® Indexes, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total mar...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RMAX RE/MAX HOLDINGS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LOCO EL POLLO LOCO HOLDINGS INC
DIN DINE BRANDS GLOBAL INC.
MSGS MADISON SQUARE GARDEN SPORTS CORP. CLASS A
TCI TRANSCONTINENTAL REALTY INVESTORS INC
RDFN REDFIN CORPORATION
NANX NANOPHASE TECHNOLOGIES CORP.
BH BIGLARI HOLDINGS B
PAYS PAYSIGN INC
BBIO BRIDGEBIO PHARMA
VIAC VIACOMCBS INC. CLASS B
HIMS HIMS AND HERS HEALTH INC (A)
OSCR OSCAR HEALTH
LMND LEMONADE INC
ASTS AST SPACEMOBILE INC
SRM SRM ENTERTAINMENT INC
LGCY LEGACY EDUCATION INC.
BATRA LIBERTY MEDIA CORPORATION
OXOTECH OXO TECHNOLOGIES HLDG PLC
PHH PARK HA BIOLOGICAL TECHNOLOGY CO. LTD.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.